SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
-----------------------
FORM 8
AMENDMENT TO APPLICATION OR REPORT
FILED PURSUANT TO SECTION 12, 14, OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
-----------------------
Commission File No. 1-9875
-----------------------
STANDARD COMMERCIAL CORPORATION
AMENDMENT NO. 1
---------------
The undersigned registrant hereby amends the following items, financial
statements, exhibits or other portions of its report on Form 10-Q for the
quarter ended September 30, 1994 as set forth below:
Part II, Item 6, EXHIBITS AND REPORTS ON FORM 8-K, is being amended to
include the following additional exhibit:
(27) Financial Data Schedule
SIGNATURES
----------
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned, thereunto duly authorized.
Dated: January 19, 1995
STANDARD COMMERCIAL CORPORATION
(Registrant)
By /s/ Guy M Ross
-----------------------------
Vice President
<PAGE> 2
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED Exhibit 27
FROM THE CONSOLIDATED BALANCE SHEET, CONSOLIDATED STATEMENT OF
INCOME AND RETAINED EARNINGS, AND IS QUALIFIED IN ITS ENTIRETY BY
REFERENCE TO SUCH FINANCIAL STATEMENTS.
<TABLE>
<CAPTION>
Item Item September 30,
Number Description 1994 Reference
In thousands except per share information
<S> <C> <C>
5-02(1) Cash $ 31,677 1
5-02(2) Marketable securities 932 1
5-02(3)(a)(1) Notes and accounts receivable- trade 235,179 3
5-02(4) Allowances for doubtful accounts 0 4
5-02(6) Inventory 382,294 1
5-02(9) Total current assets 658,295 1
5-02(13) Property, plant and equipment 133,432 3
5-02(14) Accumulated depreciation 0 4
5-02(18) Total assets 840,903 1
5-02(21) Total current liabilities 583,212 1
5-02(22) Long-term debt and convertible subordinated debentures 99,291 1
5-02(28) ESOP redeemable preferred stock 9,200 1
5-02(29) Preferred stock- no mandatory redemption 0 1
5-02(30) Common stock 2,187 1
5-02(31) Other stockholders' equity 100,419 1
5-02(32) Total liabilities and equity 840,903 1
5-03(b)1(a) Sales 478,298 2
5-03(b)1 Sales 478,298 2
5-03(b)2(a) Cost of sales 447,233 2
5-03(b)2 Cost of sales 447,233 2
5-03(b)3 Other costs and expenses 0 2
5-03(b)5 Provision for doubtful accounts and notes 0 4
5-03(b)(8) Interest and amortization of debt discount 0 4
5-03(b)(10) Income (loss) before taxes 3,279 2
5-03(b)(11) Income taxes (4,938) 2
5-03(b)(14) Loss from continuing operations (5,248) 2
5-03(b)(15) Loss from discontinued operations 0 2
5-03(b)(17) Extraordinary items 0 2
5-03(b)(18) Cumulative effect of accounting changes 0 2
5-03(b)(19) Net loss (5,248) 2
5-03(b)(20) Loss per share- primary (0.64) 2
5-03(b)(20) Loss per share- fully diluted (0.64) 2
</TABLE>
Index to references:
1 - Consolidated balance sheet
2 - Consolidated statement of income and retained earnings
3 - Net balance presented in consolidated balance sheet
4 - Not separately disclosed due to materiality guidelines
